XML 28 R15.htm IDEA: XBRL DOCUMENT v3.20.4
Note 9 - Commitments and Contingencies
12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Commitments and Contingencies Disclosure [Text Block]
9.
         
Commitments and Contingencies
 
Financial Covenants
On
July 13, 2020,
the Company, entered into a Manufacturing and Supply Amending Agreement
#2
with CBR Systems, Inc. (“CBR”) with an effective date of
July 13, 2020 (
the “Amendment”). The Amendment amends the Manufacturing and Supply Agreement entered into on
May 15, 2017
and Amendment
#1
dated
March 16, 2020
by the Company and CBR. The Amendment, among other things, revised the amount of certain products to be purchased, pricing of those products and removal of the safety stock requirement. In addition, the Amendment updated the financial requirement to exclude convertible debt from the definition of short-term debt under events or conditions that constitute a default. The Amendment states that the Company's cash balance and short-term investments net of non-convertible debt and borrowed funds that are payable within
one
year must be greater than
$1,000,000
at any month end. The Company was in compliance with this agreement as of
December 31, 2020.
 
Potential Severance Payments
We have entered into an employment agreement with the Company Chief Executive Officer under which payment and benefits would become payable in the event of termination by us for any reason other than cause, or upon a change in control of our Company, or by the employee for good reason.
 
Contingencies and Restricted Cash
In fiscal
2016,
the Company signed an engagement letter with a strategic consulting firm (“Mavericks”). Included in the engagement letter was a success fee due upon the successful conclusion of certain transactions. On
May 4, 2017,
a lawsuit was filed in California Superior Court against the Company and its Chief Executive Officer by the consulting firm, which argued that it was owed a transaction fee of
$1,000,000
under the terms of the engagement letter due to the conversion of the Boyalife debentures in
August 2016.
In
October 2017,
to streamline the case by providing for the dismissal of claims against the Company's Chief Executive Officer based on alter ego theories and without acknowledging any liability, the Company deposited
$1,000,000
with the Court, which was recorded as restricted cash. The trial completed in
February 2020
with an adverse jury verdict in favor of Mavericks in the total amount of
$1,000,000.
As a result, the Company recorded in other current liabilities a
$1,400,000
loss in general and administrative expenses for the year ended
December 31, 2019.
The loss included the
$1,000,000
transaction fee and an estimated
$400,000
in interest due. The
$1,000,000
deposited with the court was used to settle the transaction fee. After that jury verdict, Mavericks and the Company reached agreement for the interest start date and the total amount of Mavericks' trial-related expenses that must be reimbursed by the Company as result of the verdict. On
May 1, 2020
the parties agreed that the Company would pay Mavericks
$480,000,
representing
$369,000
for interest and
$111,000
for trial-related expenses. Additionally, the Company agreed
not
to contest the jury verdict and allowed the Court to release the
$1,000,000
cash bond deposited by the Company early in the litigation to Mavericks, effectively ending the case.
 
In the normal course of operations, the Company
may
have disagreements or disputes with customers, employees or vendors. Such potential disputes are seen by management as a normal part of business. As of
December 31, 2020,
except as disclosed, management believes any liability that
may
ultimately result from the resolution of these matters will
not
have a material adverse effect on the Company's consolidated financial position, operating results or cash flows.
 
Warranty
The Company offers a warranty on all of its non-disposable products of
one
to
two
years. The Company warrants disposable products through their expiration date, which is
three
years for most products. The Company periodically assesses the adequacy of the warranty reserves and adjusts as necessary.
 
The warranty liability is included in other current liabilities in the consolidated balance sheets. Changes in the Company's warranty reserve, which is included in other current liabilities in the accompanying consolidated balance sheet is as follows:
 
   
Year Ended December 31,
 
   
2020
   
2019
 
Beginning balance
  $
277,000
    $
186,000
 
Warranties originated during the year
   
71,000
     
254,000
 
Claims settled made during the year
   
(212,000
)    
(154,000
)
Changes in reserve estimate
   
18,000
     
(9,000
)
Ending balance
  $
154,000
    $
277,000